Ubs Group Ag Pro Mis Neurosciences Inc. Transaction History
Ubs Group Ag
- $611 Billion
- Q3 2025
A detailed history of Ubs Group Ag transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,506 shares of PMN stock, worth $977. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,506Holding current value
$977% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding PMN
# of Institutions
25Shares Held
10MCall Options Held
0Put Options Held
0-
Ally Bridge Group (Ny) LLC New York, NY6.23MShares$2.43 Million2.7% of portfolio
-
Armistice Capital, LLC New York, NY2.97MShares$1.16 Million0.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3295KShares$115,1220.03% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il170KShares$66,3300.0% of portfolio
-
Hrt Financial LP New York, NY68.1KShares$26,5420.0% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...